Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Scientipôle Capital is a France-based early-stage venture capital firm and regional investment vehicle focused on innovative technology startups in the Paris-Saclay and broader Ile-de-France ecosystem. The organization invests primarily at seed and early stage and provides capital alongside operational support in areas such as finance, sales, engineering, marketing, intellectual property, and HR. Its sector focus includes industry 4.0, greentech, and health/medtech, with public descriptions indicating that drug-focused biotechnology is generally excluded. "Scientipôle IDF Capital" appears to refer to the firm's Ile-de-France investment fund rather than to a separate drug-development operating company. For biotech analysts, this is best classified as a healthcare-adjacent investor with exposure to medtech/healthtech rather than a therapeutic product developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Scientipôle Capital.